IRB

HISTORY

In 1996, St. Paul’s Hospital Iloilo Ethics Committee was constituted. This was the beginning of Bioethics Committee. It was on June 27, 2006 that the Ethics Committee revised their existing policies and guidelines for the comprehensive and efficient review of researches that involved human participants. In cases of research and experimentation involving human subjects, the Committee made sure that the Clinical researches conform to the moral and scientific principles that justify the research.

The participants were well informed of the Study. Informed consents were signed, the subjects were free to terminate the study on any stage and for whatever reason and that the clinical research followed the national and international guidelines for the protection of the safety and well-being of the participants.

On November 1, 2007, the name of Ethics Committee was changed to St. Paul’s Hospital Ethics Review Board (IERB). In July 2014, the Administrator appointed Sr. Henrietta Esmero, SPC as a new member to replace Sr. Rowena Rodil, SPC who received a new assignment in Luzon. The Administrator also changed the name of St. Paul’s Hospital Ethics Review Board to Institutional Review Board Committee.

On February 27, 2015, Philippine Health Research Ethics Board released a memorandum addressing all the Ethics Review Committees to submit application for Accreditation in order to review clinical trials research protocols of drugs and devices for FDA registration. On April 30 of 2015, SPHI submitted an application for Level 3 Accreditation to the Philippines Health Research Ethics Board. This move was an evidence of SPHI’s commitment to submit to International and National Standard practices pertaining to the conduct of all types of researches.

See more history...

JAIME MANILA, MD, FPOGS

Chairman

OB-Gynecology

The following are the members of the organized committee as of May 1, 2025

ROWENA COSCA, MD, FPPA

Co-Chairman

Clinical Psychiatrist

MA. CECILIA FLORETE, MD, FPCP, FPSG, FPSDE

Member-Secretary

Internist-Gastroenterologist

VENERIO GASATAYA JR., MD, FPCS, FPSG, MHA

Member

General Surgeon

RONALD LATAP, MD, FPOGS, FSGOP, FPSCPC

Member

OB-Gynecology, Gynecologic Oncologist, Colposcopist

ATTY. JOSE MARI BENJAMIN TIROL

Member

Lawyer

MARIA THELMA SERVIDAD, RN, MAN

Member

Businesswoman

CHRISTOPHER TABSING, LPT

Member

School Principal II

MA. ROMY ALEXIS CONSULTA, MEd

Member

Professor

SR. GERTRUDE CARYLS KUEBLER, SPC

Member

Religious

Frequently Asked Questions (FAQs)

Please reach us at sphirbresearch@gmail.com if you cannot find an answer to your question.

1. What are the requirements for Initial Submission

Letter of Application & Complete Protocol
Protocol Summary
Investigator’s Brochure (for Clinical Trials)
Data collection form/s
Informed Consent Forms (English, Tagalog, and local dialect (Hiligaynon))
CV (for clinical trials- Principal Investigator and his/her co-investigators), (for Researcher Initiated protocol-Researcher and Adviser).
GCP Certificate of the Principal Investigator (PI) and his/her co-investigators
GCP Certificate of the Principal Investigator (PI) and his/herco-investigators(Form 2.1)
Valid PRC License
COI Declaration and Confidentiality Agreement
GANTT Chart (as necessary)
Advertisement, Diary card and other related documents (for Clinical Trials)
Case report form/s, trial Materials (for Clinical Trials)
Certificate of Technical Review (for Researcher Initiated protocol)
Insurance Certificate (for Clinical Trials)
Technical review approval/endorsement of the Department
Decision of Ethics Review if reviewed by other Research Ethics Committee/s
Material Transfer Agreement (for Clinical Trials if applicable)
Budget
Clinical Trial Agreement- Draft is acceptable (for Clinical Trials)
Letter of Approval from Hospital Administrator and Data Protection Officer
Waiver of Informed Consent Form (if applicable)

2. How many copies of the protocol should need to submit?

The SPHI-IRB required to submit electronic copy of the protocol package for review and approval and three (3) hard copies should be submitted.

3. How long is the validity of the ethical clearance?

The validity of the ethical approval is for one (1) year only, the Principal Investigator/Researcher should apply for a Continuing Review.

4. When is the deadline of submission?

The IRB cut-off is every 21st of the month (until 4:00pm only).

5. Can IRB reviewed protocols who will be conducted in other institutions??

No, the IRB will only review those protocols whose SPHI is part of their study setting.

6. When is the IRB meeting?

The IRB meeting is every 2nd Thursday of the month.

INSTITUTIONAL REVIEW BOARD (IRB)

HISTORY

IRB MIssion and vision

Mission

Vision

IRB ORGANIZATIONAL CHART

SPHI-IRB SOP 13th Edition

National and International guidelines

IRB "Flow CHART OF PROTOCOL SUBMISSIONS"

Frequently Asked Questions (FAQs)

Meeting dates

IRB Meeting: Every 2nd Thursday of the month

CONTACT US

St. Paul's Hospital of Iloilo, Inc - Institutional Review Board 4th Floor Cancer Center Building